Onboarding pipeline
From inbound inquiry to confirmed, prepared appointment. The Orchestrator and Eligibility agents auto-advance cards where they can.
Prior authorizations
Work by exception. Routine submissions run automatically; this queue shows what needs a person.
Approval rate · 28d
87%▲ 4%
Median time to decision
2.3days
Denials · 28d
6▲ 2
Appeals drafted
4
Click any row to open the authorization package. Every clinical criterion in the package carries a source citation chip.
Spravato REMS compliance
A compliance ledger for the SPRAVATO REMS program. Patient Monitoring Forms are due within 7 days of each dose.
Patient Monitoring Form queue
2-hour on-site monitoring required each session · submit PMF within 7 daysCertifications & recertification
Site certificationActive
Dr. Hoang, R. (Medical Director)Recert Aug 2026
Dr. Patel, S.Recert Nov 2026
Dr. Okafor, J.Recert Jul 2026 · 60 days
NP Sandoval, M.Recert Feb 2027
Serious adverse events of interest · log
0 openNo SAEs reported in the last 90 days.
Reportable events: sedation, dissociation, respiratory depression, and hypertension requiring intervention. Reported to Janssen within required timelines.
Assessments — Daniela R.
Patient #4418 · Spravato induction, week 4 · scores tracked across treatment. Switch patient from the work queue.
!
C-SSRS escalation cleared at last visit. PHQ-9 item 9 returned to 0 on May 20. Prior positive screen on Apr 8 was triaged to the on-call clinician same day.
PHQ-9
8Mild
▼ 13 since intake · meaningful change (≥6)
MADRS
14Mild
▼ 19 since intake · meaningful change (≥10)
GAD-7
6Mild
▼ 8 since intake
C-SSRS
No current ideationCleared
Last screen May 20
MDQ (screen)
Negative—
Screen only · clinician review